Kidney Diseases Clinical Trial
— REMA-CKDOfficial title:
Reduction of Metabolic Acidosis in Patients With Chronic Kidney Disease in Stage 4 and 5
This clinical trial aims to investigate and test the effect of an acid/base diet in chronic kidney disease (CKD) patients, CKD stage 4 and 5. The trial is guided by the hypothesis that an acid/base diet will reduce the degree of acidosis and simultaneously reduce the need for bicarbonate supplements.
Status | Recruiting |
Enrollment | 20 |
Est. completion date | November 20, 2023 |
Est. primary completion date | June 20, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Chronic acidosis (plasma-bicarbonate under 22 mmol/l at multiple measures within the last 12 months). - Diagnosed with non-dialysis needed chronic kidney disease in stage 4 and 5 (eGFR below 30 ml/min/1,73 m2) - Of legal age and over 18 of years - Understand danish and understand the written material - Able to cooperate about the diet - Able to take pictures with their phone or willing to learn Exclusion Criteria: - Vegan and vegetarian with very low intake of animal protein (below 25 g/day) - Pregnant or breast feeding - Patients with short bowel syndrome, bricker bladder, pancreatitis or any other known malabsorption problem - Potassium above 5 mmol/l - Ongoing infection |
Country | Name | City | State |
---|---|---|---|
Denmark | Nordshjaellands Hospital | Hillerød |
Lead Sponsor | Collaborator |
---|---|
Nordsjaellands Hospital | University of Copenhagen |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Plasma-Potassium | mmol/l | 6 weeks | |
Other | Plasma-calcium | mmol/l | 6 weeks | |
Other | Plasma-magnesium | mmol/l | 6 weeks | |
Other | Plasma-inorganic phosphorous | mmol/l | 6 weeks | |
Primary | Plasma-total carbon dioxide (CO2) | mmol/l | 6 weeks | |
Secondary | Plasma-alkaline phosphatase | U/l | 6 weeks | |
Secondary | Plasma-sodium ion | mmol/l | 6 weeks | |
Secondary | Plasma-creatinine | umol/l | 6 weeks | |
Secondary | Plasma-parathyroid hormone | pmol/l | 6 weeks | |
Secondary | Plasma-carbamide | mmol/l | 6 weeks | |
Secondary | Plasma-albumin | g/l | 6 weeks | |
Secondary | Urine-phosphorous | mmol/d | 6 weeks | |
Secondary | Urine-sodium | mmol/d | 6 weeks | |
Secondary | Urine-potassium | mmol/d | 6 weeks | |
Secondary | Urine-carbamide | mmol/d | 6 weeks | |
Secondary | Urine-albumin | mg/d | 6 weeks | |
Secondary | Urine-magnesium | mmol/d | 6 weeks | |
Secondary | Urine-creatinine | mmol/d | 6 weeks | |
Secondary | Urine-calcium | mmol/d | 6 weeks | |
Secondary | Total acid excretion in urine | mmol/d | 6 weeks | |
Secondary | Urine-pH | pH | 6 weeks | |
Secondary | Urine ammonium-ion (NH4+) excretion | mmol/d | 6 weeks | |
Secondary | Urine net acid excretion | mmol/d | 6 weeks | |
Secondary | Urine bicarbonate | mmol/l | 6 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03246984 -
VALUE- Vascular Access Laminate eUropean Experience. A Post Market Surveillance Study to Assess the Safety and Effectiveness of VasQ
|
N/A | |
Completed |
NCT03545113 -
Graft-first Versus Fistula-first in Older Patients With End-stage Kidney Disease
|
N/A | |
Recruiting |
NCT05100017 -
Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
|
N/A | |
Recruiting |
NCT04559321 -
Holmium Vs Trilogy Kidney Stones GUY's 1-2
|
Phase 3 | |
Recruiting |
NCT05036850 -
China Kidney Patient Trials Network
|
||
Completed |
NCT04037436 -
Functional Exercise and Nutrition Education Program for Older Adults
|
N/A | |
Active, not recruiting |
NCT01529658 -
Renal Hypothermia During Partial Nephrectomy
|
N/A | |
Completed |
NCT01679587 -
Dose Escalation Study to Investigate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BAY85-3934 in Subjects With Chronic Kidney Disease (CKD)
|
Phase 1 | |
Completed |
NCT01155141 -
Idiopathic Focal Segmental Glomerulosclerosis (FSGS) and Treatment With ACTH
|
Phase 4 | |
Completed |
NCT00755690 -
Study of Dietary Phosphate and Mineral Homeostasis in Early Chronic Kidney Disease
|
N/A | |
Recruiting |
NCT05759754 -
Effects of Traditional Chinese Medicine (GSJYF) in Children With Inherited Proteinuric Kidney Disease
|
N/A | |
Completed |
NCT03213158 -
Ixazomib for Desensitization
|
Phase 2 | |
Active, not recruiting |
NCT02237352 -
Mechanisms of Diabetic Nephropathy in Ecuador
|
||
Recruiting |
NCT06067867 -
Kidney and Pregnancy Registry
|
||
Recruiting |
NCT04110080 -
Enhanced Recovery After Surgery in Kidney Transplant Donors
|
N/A | |
Active, not recruiting |
NCT04876963 -
HOLT-ED: Holter-monitoring in End-stage Renal Disease
|
||
Enrolling by invitation |
NCT05324878 -
Honoring Individual Goals and Hopes: Implementing Advance Care Planning for Persons With Kidney Disease on Dialysis
|
||
Not yet recruiting |
NCT03899298 -
Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions
|
Phase 1 | |
Active, not recruiting |
NCT04631965 -
Healthcare Transition of Adolescents With Chronic Health Conditions
|
||
Completed |
NCT03394859 -
Electronic Medical Records and Genomics (eMERGE) Phase III
|